131st MAINE LEGISLATURE
LD 1428 LR 922(01)
An Act to Ensure Treatment for MaineCare Recipients with Serious Mental Illness by Prohibiting the Requirements for Prior Authorization and Step Therapy for Medications
Preliminary Fiscal Impact Statement for Original Bill
Sponsor: Rep. Madigan of Waterville
Committee: Health and Human Services
Fiscal Note Required: Yes
             
Preliminary Fiscal Impact Statement
FY 2023-24 FY 2024-25 Projections  FY 2025-26 Projections  FY 2026-27
Net Cost (Savings)
General Fund $3,977,445 $4,091,972 $4,091,972 $4,091,972
Appropriations/Allocations
General Fund $3,977,445 $4,091,972 $4,091,972 $4,091,972
Federal Expenditures Fund $9,723,799 $9,611,636 $9,611,636 $9,611,636
Federal Block Grant Fund $207,716 $205,352 $205,352 $205,352
Revenue
Federal Expenditures Fund $9,723,799 $9,611,636 $9,611,636 $9,611,636
Federal Block Grant Fund $207,716 $205,352 $205,352 $205,352
Fiscal Detail and Notes
The Department of Health and Human Services will require General Fund appropriations of $3,977,445 in fiscal year 2023-24 and $4,091,972 in fiscal year 2024-25 associated with changes to the prior authorization requirements and step therapy protocols under the MaineCare program for prescription drugs used to assess or treat serious mental illness. Federal Expenditures Fund and Federal Block Grant Fund allocations will also be required for the FMAP match.